4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-21-026800
Director sold 30,375 shares at an average $152.48 ($4,631,583)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −3,216 | $150.65 | $484,491 | 17,159 | D |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −1,578 | $150.65 | $237,726 | 167,253 | I |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −6,403 | $151.49 | $970,022 | 10,756 | D |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −3,144 | $151.49 | $476,300 | 164,109 | I |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −3,139 | $152.38 | $478,309 | 7,617 | D |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −1,540 | $152.38 | $234,660 | 162,569 | I |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −4,519 | $153.54 | $693,842 | 3,098 | D |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −2,218 | $153.54 | $340,549 | 160,351 | I |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −2,281 | $154.57 | $352,564 | 817 | D |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −1,119 | $154.57 | $172,959 | 159,232 | I |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −268 | $155.27 | $41,613 | 549 | D |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −132 | $155.27 | $20,496 | 159,100 | I |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −549 | $156.54 | $85,941 | 0 | D |
| Bolzon Bradley J PhD Director | 2021-06-28 | Sale | −269 | $156.54 | $42,110 | 158,831 | I |
| Open-market sales · 30,375 sh · avg $152.48 · $4,631,583 | |||||||
Loading xslF345X03/doc4.xml…